Atlas Trials

Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

Clinical trial NCT03447782 · COMPLETED

Trial details

NCT number
NCT03447782
Sponsor
Boston Children's Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
New Daily Persistent Headache (NDPH)
Start date
2018-07-23
Primary completion
2020-11-20
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.